# Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

> **NCT00761319** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 705 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
- **DRUG:** Latanoprost ophthalmic solution 0.005% (XALATAN®)

## Key facts

- **NCT ID:** NCT00761319
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 705 (ACTUAL)
- **Last updated:** 2012-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761319, "Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00761319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*